Eflornithine
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for Eflornithine, covering 2007-06-21 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas [Phase 1, Phase 2]